Acucela

Developing innovative drugs and devices to preserve and restore vision

placeSeattle, Washington, United States calendar_todayFounded 2002 groups45 employees language acucela.com

Registered entities

Innovation

65 patent families (41 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Electricity & electronics; filing pace slowing. Cited 23,440 times.

YearFilings
201514
201615
20175
20184
20197
20209
202126
202227
202327
202424
202513
20261

Investor mix

8 investors on record; lead investors include St. Paul’s Lutheran Church.

Investor typeCountShare
Venture capital225%
Private equity113%
Other / undisclosed563%
Coming soon